Functional silver nanoparticles synthesis from sustainable point of view: 2000 to 2023‒A review on game changing materials

KMF Hasan, L **aoyi, Z Shaoqin, PG Horváth, M Bak… - Heliyon, 2022 - cell.com
The green and facile synthesis of metallic silver nanoparticles (AgNPs) is getting
tremendous attention for exploring superior applications because of their small dimensions …

[HTML][HTML] Mode of antiviral action of silver nanoparticles against HIV-1

HH Lara, NV Ayala-Nuñez, L Ixtepan-Turrent… - Journal of …, 2010 - Springer
Silver nanoparticles have proven to exert antiviral activity against HIV-1 at non-cytotoxic
concentrations, but the mechanism underlying their HIV-inhibitory activity has not been not …

Transmission of drug-resistant HIV-1 is stabilizing in Europe

J Vercauteren, AMJ Wensing… - The Journal of …, 2009 - academic.oup.com
The SPREAD Programme investigated prospectively the time trend from September 2002
through December 2005 of transmitted drug resistance (TDR) among 2793 patients in 20 …

Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection

JD Croxtall - Drugs, 2012 - Springer
Etravirine (Intelence®) is an orally administered next-generation non-nucleoside reverse
transcriptase inhibitor (NNRTI). It is approved for the treatment of HIV-1 infection in treatment …

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection

VS Gill, VD Lima, W Zhang, B Wynhoven… - Clinical infectious …, 2010 - academic.oup.com
Background There have been limited studies evaluating temporal changes in the incidence
of detection of drug resistance among human immunodeficiency virus type 1 (HIV-1) isolates …

Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe

A De Luca, D Dunn, M Zazzi, R Camacho… - The Journal of …, 2013 - academic.oup.com
HIV-1 drug resistance represents a major obstacle to infection and disease control. This
retrospective study analyzes trends and determinants of resistance in antiretroviral treatment …

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

B Bartmeyer, C Kuecherer, C Houareau, J Werning… - PloS one, 2010 - journals.plos.org
Background The aim of this study is to analyse the prevalence of transmitted drug
resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 …

Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database

F Lombardi, A Giacomelli, D Armenia, A Lai… - International Journal of …, 2021 - Elsevier
Despite successful antiretroviral therapy (ART), patients infected with human
immunodeficiency virus (HIV) can develop multi-class drug resistance (MDR). This …

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997–2011

I Bontell, A Häggblom, G Bratt, J Albert, A Sönnerborg - PloS one, 2013 - journals.plos.org
Objective Describe trends in antiretroviral treatments and drug resistance mutations among
Swedish HIV-patients over time 1997–2011. Methods Treatment histories, viral sequences …

Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment

H **ng, X Wang, L Liao, Y Ma, B Su, J Fu, J He… - PloS one, 2013 - journals.plos.org
Background A critical indicator of the future success of highly active antiretroviral therapy
(HAART) is the incidence of HIV drug resistance, which has not been studied in China on …